IL1RL1 single nucleotide polymorphisms are associated with asthma in the Iranian population.


Journal

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
ISSN: 1122-0643
Titre abrégé: Monaldi Arch Chest Dis
Pays: Italy
ID NLM: 9307314

Informations de publication

Date de publication:
28 Dec 2021
Historique:
received: 24 11 2020
accepted: 20 12 2021
pubmed: 30 12 2021
medline: 16 6 2022
entrez: 29 12 2021
Statut: epublish

Résumé

Asthma is a chronic and multifactorial disease which is known to result from environmental and genetic factors. Interleukin 1 receptor-like 1 (IL1RL1) is a receptor, which promotes inflammatory responses after binding to its ligand IL-33. Several studies have shown that IL1RL1 gene polymorphisms are related to susceptibility or protection to asthma. The objective of this study was to evaluate the association between two IL1RL1 single nucleotide polymorphisms (rs10208293 and rs1041973) and the risk of asthma in the Iranian population. We performed genotyping of the IL1RL1 SNPs in 126 adult asthmatics and 300 healthy controls using TaqMan genotyping assay. Moreover, total serum IgE level, eosinophil count, and skin prick test were accomplished. The results indicated that the AA genotype of rs10208293 was positively associated with asthma susceptibility (p=0.028). We did not find any association between rs1041973 and asthma. Overall, our findings indicate that rs10208293 has a positive association with asthma in the Iranian population.

Identifiants

pubmed: 34964571
doi: 10.4081/monaldi.2021.1697
doi:

Substances chimiques

IL1RL1 protein, human 0
Interleukin-1 Receptor-Like 1 Protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Maral Ranjbar (M)

Department of Immunology, School of Medicine, Iran University of Medical Science, Tehran. ranjbar.maral@iums.ac.ir.

Mojdeh Matloubi (M)

Department of Immunology, School of Medicine, Iran University of Medical Science, Tehran. matlobi.m@iums.ac.ir.

Shaghayegh Sadegh (S)

Department of Immunology, School of Medicine, Iran University of Medical Science, Tehran. sadegh.s@tak.iums.ac.ir.

Morteza Fallahpour (M)

Department of Allergy, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran. fallahpour.m@iums.ac.ir.

Leila Janani (L)

Department of Biostatistics, School of Public Health, Iran University of Medical Science, Tehran. Janani.l@iums.ac.ir.

Mohammad-Ali Assarehzadegan (MA)

Department of Immunology, School of Medicine, Iran University of Medical Science, Tehran. assarehma@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH